tirzepatide on ingestive behavior phase 3 trial 80 weeks weight change in adults with overweight or obesity: a randomized 6-week 1 More data on Retatrutide dropped – Tirzepatide reduces food intake and

The story repeats itself for alleged increases to the risk of developing vertigo and other vestibular disorders , acid reflux , and thyroid cancer

GLP-1 medications work by delaying stomach emptying or slowing the intestines so that the person feels full for longer and appetite is reduced

Maintaining a balanced diet with adequate protein, fiber, and hydration can help you avoid potential deficiencies

No sterile water for injection (SWFI) does not contain a preservative, meaning bacterial contamination begins immediately upon opening and worsens with each needle puncture if youre drawing multiple doses from the same vial

Available from: Osterweis M, Kleinman A, Mechanic D

Consider holding your next dose and contacting your prescriber if you experience severe or persistent gastrointestinal symptoms